Retraction Note: Strategies for efficient production of heterologous proteins in Escherichia coli

In recent years, the number of recombinant proteins used for therapeutic applications has increased dramatically. Production of these proteins has a remarkable demand in the market. Escherichia coli offers a means for the rapid and economical production of recombinant proteins. These advantages, coupled with a wealth of biochemical and genetic knowledge, have enabled the production of such economically therapeutic proteins such as insulin and bovine growth hormone. These demands have driven the development of a variety of strategies for achieving high-level expression of protein, particularly involving several aspects such as expression vectors design, gene dosage, promoter strength (transcriptional regulation), mRNA stability, translation initiation and termination (translational regulation), host design considerations, codon usage, and fermentation factors available for manipulating the expression conditions, which are the major challenges is obtaining the high yield of protein at low cost.

[1]  W. R. Farmer,et al.  Reduction of aerobic acetate production by Escherichia coli , 1997, Applied and environmental microbiology.

[2]  Copy-control tightly regulated expression vectors based on pBAC/oriV. , 2004, Methods in molecular biology.

[3]  C. Cote,et al.  Construction of transcriptional and translational lacZ gene reporter plasmids for use in Streptococcus mutans. , 2002, Journal of microbiological methods.

[4]  J. Keasling,et al.  Construction and characterization of F plasmid-based expression vectors. , 1998, Biotechnology and bioengineering.

[5]  G. Bennett,et al.  Characterization of a pH‐inducible promoter system for high‐level expression of recombinant proteins in Escherichia coli , 1995, Biotechnology and bioengineering.

[6]  H. Unno,et al.  Programmed Escherichia coli Cell Lysis by Expression of Cloned T4 Phage Lysis Genes , 2001, Biotechnology progress.

[7]  J. Bailey,et al.  Expression of Vitreoscilla Hemoglobin in Escherichiacoli Enhances Ribosome and tRNA Levels: A Flow Field‐Flow Fractionation Study , 1999, Biotechnology progress.

[8]  C. Hwang,et al.  High-density Escherichia coli cultivation process for hyperexpression of recombinant porcine growth hormone. , 1992, Enzyme and microbial technology.

[9]  S. Karlin,et al.  Correlations between Shine-Dalgarno Sequences and Gene Features Such as Predicted Expression Levels and Operon Structures , 2002, Journal of bacteriology.

[10]  M. Gasson,et al.  Lactococcus lactis: high‐level expression of tetanus toxin fragment C and protection against lethal challenge , 1993, Molecular microbiology.

[11]  G. Bennett,et al.  Metabolic Engineering of Escherichia coli To Enhance Recombinant Protein Production through Acetate Reduction , 1995, Biotechnology progress.

[12]  J. Ross,et al.  mRNA stability in mammalian cells. , 1995, Microbiological reviews.

[13]  L. Isaksson,et al.  A host/plasmid system that is not dependent on antibiotics and antibiotic resistance genes for stable plasmid maintenance in Escherichia coli. , 2004, Journal of biotechnology.

[14]  G. Storz,et al.  Controlling mRNA stability and translation with small, noncoding RNAs. , 2004, Current opinion in microbiology.

[15]  P. Kyslík,et al.  Optimization of the host–plasmid interaction in the recombinant Escherichia coli strains overproducing penicillin G acylase , 2004 .

[16]  M. Inouye,et al.  Enhancement of Translation Initiation by A/T-Rich Sequences Downstream of the Initiation Codon in Escherichia coli , 2004, Journal of Molecular Microbiology and Biotechnology.

[17]  Identification of peptide inhibitors of Pseudomonas aeruginosa exotoxin A function using a yeast two-hybrid approach. , 2003, FEMS microbiology letters.

[18]  S. Corisdeo,et al.  Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions. , 2004, Protein expression and purification.

[19]  S. Jana,et al.  Purification of streptomycin adenylyltransferase from a recombinant Escherichia coli. , 2005, Protein expression and purification.

[20]  J. Keasling,et al.  Low-copy plasmids can perform as well as or better than high-copy plasmids for metabolic engineering of bacteria. , 2000, Metabolic engineering.

[21]  M. Dreyfus,et al.  The C‐terminal half of RNase E, which organizes the Escherichia coli degradosome, participates in mRNA degradation but not rRNA processing in vivo , 1999, Molecular microbiology.

[22]  V. Sahai,et al.  Enhanced expression of the recombinant lethal factor of Bacillus anthracis by Fed-Batch culture. , 2001, Biochemical and biophysical research communications.

[23]  L. Jolliffe,et al.  Extracellular proteases modify cell wall turnover in Bacillus subtilis , 1980, Journal of bacteriology.

[24]  M. Ehrenberg,et al.  Activities of constitutive promoters in Escherichia coli. , 1999, Journal of molecular biology.

[25]  T. Afonyushkin,et al.  Coincident Hfq binding and RNase E cleavage sites on mRNA and small regulatory RNAs. , 2003, RNA.

[26]  H. Musto,et al.  The effect of expression levels on codon usage in Plasmodium falciparum , 2004, Parasitology.

[27]  M. Yamashita,et al.  Molecular analysis of promoter elements from Propionibacterium freudenreichii. , 2004, Journal of bioscience and bioengineering.

[28]  N. Nakashima,et al.  A novel system for expressing recombinant proteins over a wide temperature range from 4 to 35°C , 2004 .

[29]  D K Robinson,et al.  Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.

[30]  J. K. Deb,et al.  Construction of fusion vectors of corynebacteria: expression of glutathione-S-transferase fusion protein in Corynebacterium acetoacidophilum ATCC 21476. , 2002, FEMS microbiology letters.

[31]  S. Chamow,et al.  Therapeutic antibody expression technology. , 2001, Current opinion in biotechnology.

[32]  J. Toivonen,et al.  Gene dosage and selective expression modify phenotype in a Drosophila model of human mitochondrial disease. , 2003, Mitochondrion.

[33]  F. Bolivar,et al.  Pathway engineering for the production of aromatic compounds in Escherichia coli , 1996, Nature Biotechnology.

[34]  M. Inouye,et al.  Translational Enhancement by an Element Downstream of the Initiation Codon in Escherichia coli* , 1999, The Journal of Biological Chemistry.

[35]  M. Springer,et al.  The relationship between translational control and mRNA degradation for the Escherichia coli threonyl-tRNA synthetase gene. , 2001, Journal of molecular biology.

[36]  Isabelle lost,et al.  mRNAs can be stabilized by DEAD-box proteins , 1994, Nature.

[37]  J. Kane,et al.  Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. , 1995, Current opinion in biotechnology.

[38]  M. Romantschuk,et al.  The bacterial type III secretion system‐associated pilin HrpA has an unusually long mRNA half‐life , 2004, FEBS letters.

[39]  T. Thomas,et al.  Low temperature regulated DEAD-box RNA helicase from the Antarctic archaeon, Methanococcoides burtonii. , 2000, Journal of molecular biology.

[40]  J. Swartz,et al.  Expression of Active Human Tissue-Type Plasminogen Activator in Escherichia coli , 1998, Applied and Environmental Microbiology.

[41]  G W Luli,et al.  Comparison of growth, acetate production, and acetate inhibition of Escherichia coli strains in batch and fed-batch fermentations , 1990, Applied and environmental microbiology.

[42]  J. Bailey,et al.  Expression of Alcaligenes eutrophusFlavohemoprotein and Engineered VitreoscillaHemoglobin-Reductase Fusion Protein for Improved Hypoxic Growth ofEscherichia coli , 2000, Applied and Environmental Microbiology.

[43]  G. Stormo,et al.  Translation initiation in Escherichia coli: sequences within the ribosome‐binding site , 1992, Molecular microbiology.

[44]  R. Doi,et al.  Prokaryotic promoters in biotechnology. , 1995, Biotechnology annual review.

[45]  M. Yabuta,et al.  Thermo-inducible expression of a recombinant fusion protein by Escherichia coli lac repressor mutants. , 1995, Journal of biotechnology.

[46]  B. Kirdar,et al.  High-level production of TaqI restriction endonuclease by three different expression systems in Escherichia coli cells using the T7 phage promoter , 2002, Applied Microbiology and Biotechnology.

[47]  P. Doran,et al.  Characterization of monoclonal antibody fragments produced by plant cells. , 2001, Biotechnology and bioengineering.

[48]  M. Filutowicz,et al.  Bacterial expression system with tightly regulated gene expression and plasmid copy number. , 2004, Gene.

[49]  M. Simonen,et al.  Protein secretion in Bacillus species , 1993, Microbiological reviews.

[50]  B. Bukau,et al.  The heat shock response of Escherichia coli. , 2000, International journal of food microbiology.

[51]  H. Blanch,et al.  Recombinant Protein Expression in High Cell Density Fed-Batch Cultures of Escherichia Coli , 1992, Bio/Technology.

[52]  N. Dixon,et al.  Stable high-copy-number bacteriophage lambda promoter vectors for overproduction of proteins in Escherichia coli. , 1996, Gene.

[53]  C. Branlant,et al.  Effects of pulse addition of carbon sources on continuous cultivation of Escherichia coli containing a recombinant E. coli gapA gene. , 1999, Biotechnology and bioengineering.

[54]  E. Goldman,et al.  Increased ribosomal accuracy increases a programmed translational frameshift in Escherichia coli. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Teixeira,et al.  Regulation of the flavorubredoxin nitric oxide reductase gene in Escherichia coli: nitrate repression, nitrite induction, and possible post-transcription control. , 2003, FEMS microbiology letters.

[56]  G. Venemâ,et al.  Expression of a chitinase gene from Serratia marcescens in Lactococcus lactis and Lactobacillus plantarum , 1994, Applied Microbiology and Biotechnology.

[57]  G. Venema,et al.  Production of secreted guar α-galactosidase by Lactococcus lactis , 1995, Applied Microbiology and Biotechnology.

[58]  W. Fiers,et al.  Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis , 1995, Applied and environmental microbiology.

[59]  Junmin Zhu,et al.  A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli. , 2004, Protein expression and purification.

[60]  E. Goldman,et al.  Low-usage codons in Escherichia coli, yeast, fruit fly and primates. , 1991, Gene.

[61]  N. Wan,et al.  High-level expression and stabilization of recombinant human chitinase produced in a continuous constitutive Pichia pastoris expression system. , 2001, Biotechnology and bioengineering.

[62]  K. Berndt,et al.  Codon optimization reveals critical factors for high level expression of two rare codon genes in Escherichia coli: RNA stability and secondary structure but not tRNA abundance. , 2004, Biochemical and biophysical research communications.

[63]  M. Tutino,et al.  Recombinant protein production in Antarctic Gram-negative bacteria. , 2004, Methods in molecular biology.

[64]  S. Bottomley,et al.  Production of recombinant serpins in Escherichia coli. , 2004, Methods.

[65]  Y Wang,et al.  Human insulin from a precursor overexpressed in the methylotrophic yeast Pichia pastoris and a simple procedure for purifying the expression product. , 2001, Biotechnology and bioengineering.

[66]  P. Doran,et al.  Foreign protein production in plant tissue cultures. , 2000, Current opinion in biotechnology.

[67]  T. Yamane,et al.  Dosage effect of minor arginyl- and isoleucyl-tRNAs on protein synthesis in an Escherichia coli in vitro coupled transcription/translation system. , 2001, Journal of bioscience and bioengineering.

[68]  Michael N. Hall,et al.  A role for mRNA secondary structure in the control of translation initiation , 1982, Nature.

[69]  L. Cruz-Vera,et al.  Ribosome stalling and peptidyl-tRNA drop-off during translational delay at AGA codons. , 2004, Nucleic acids research.

[70]  J. Gallant,et al.  On the directional specificity of ribosome frameshifting at a "hungry" codon. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[71]  H. Billman-Jacobe,et al.  Expression of ovine gamma interferon in Escherichia coli and Corynebacterium glutamicum , 1994, Applied and environmental microbiology.

[72]  G. Bennett,et al.  Effect of modified glucose uptake using genetic engineering techniques on high‐level recombinant protein production in escherichia coli dense cultures , 1994, Biotechnology and bioengineering.

[73]  Dong-Myung Kim,et al.  Regeneration of adenosine triphosphate from glycolytic intermediates for cell-free protein synthesis. , 2001, Biotechnology and bioengineering.

[74]  M. Inouye,et al.  Role of the AGA/AGG codons, the rarest codons in global gene expression in Escherichia coli. , 1994, Genes & development.

[75]  W. Szybalski,et al.  Construction of lacIts and lacIqts expression plasmids and evaluation of the thermosensitive lac repressor. , 1995, Gene.

[76]  D. Belin,et al.  Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter , 1995, Journal of bacteriology.

[77]  S. Gottesman,et al.  Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coli. , 2003, Genes & development.

[78]  Wentao Gao,et al.  UpGene: Application of a Web‐Based DNA Codon Optimization Algorithm , 2008, Biotechnology progress.

[79]  A G Porter,et al.  Functional importance of RNA interactions in selection of translation initiation codons , 1997, Molecular microbiology.

[80]  James C. Hu,et al.  Gene expression from plasmids containing the araBAD promoter at subsaturating inducer concentrations represents mixed populations. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[81]  K. San,et al.  Effects of glycine supplement on protein production and release in recombinant Escherichia coli , 1993, Biotechnology Letters.

[82]  A. Das.  Overproduction of proteins in Escherichia coli: vectors, hosts, and strategies. , 1990, Methods in enzymology.

[83]  J. Swartz,et al.  Advances in Escherichia coli production of therapeutic proteins. , 2001, Current opinion in biotechnology.

[84]  L. Simmons,et al.  Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli , 1996, Nature Biotechnology.

[85]  F. Baneyx.  Recombinant protein expression in Escherichia coli. , 1999, Current opinion in biotechnology.

[86]  L. Hewitt,et al.  Screening and optimizing protein production in E. coli. , 2004, Methods in molecular biology.

[87]  W. Bentley,et al.  Plasmid‐encoded protein: The principal factor in the “metabolic burden” associated with recombinant bacteria , 1990, Biotechnology and bioengineering.

[88]  M. Reuss,et al.  High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. , 2001, Biotechnology and bioengineering.

[89]  D. Nierlich,et al.  The decay of bacterial messenger RNA. , 1996, Progress in nucleic acid research and molecular biology.

[90]  J W Larrick,et al.  Producing proteins in transgenic plants and animals. , 2001, Current opinion in biotechnology.

[91]  M. Saier.  Differential codon usage: a safeguard against inappropriate expression of specialized genes? , 1995, FEBS letters.

[92]  K. Friehs,et al.  Rapid determination of plasmid copy number. , 1996, Journal of biotechnology.